Please be aware that all information shared here at Canada Pharmacy has been medically reviewed and fact-checked for accuracy. These verifications are made by board-certified medical professionals who have the authority required to state that information related to medical conditions, symptoms, procedures and tests, and standard treatment protocols is valid and truthful. This is based on current guidelines and consensuses shared amongst medical professionals, and in representation of the latest research.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
APIDRA is an insulin product prescribed to treat high blood sugar in patients with diabetes mellitus.
APIDRA and other insulins can be used for both type 1 and type 2 diabetes mellitus.
Patients with diabetes have trouble maintaining normal blood sugar levels. The body naturally produces insulin, but patients with diabetes either do not create insulin or their insulin is not effective. APIDRA helps to regulate blood sugar in these patients.
APIDRA insulin is a meal-time insulin that should be administered 15 minutes before or within 20 minutes after starting the meal. Do not skip meals if you are using meal-time insulin, as it may cause low blood sugar.
APIDRA cannot be mixed with most other types of insulins. It can be mixed with NPH insulin, but only do so under the direction of your doctor.
The active ingredient in APIDRA is insulin glulisine.
Insulin glulisine is a rapid-acting insulin. It should be used as part of a regimen with long-acting insulin.
Some medications can change blood sugar and affect treatment. These medications include:
The above medications may increase or decrease blood sugar, requiring that the dose of insulin is adjusted.
The most common adverse reaction to APIDRA and other insulin products is low blood sugar (hypoglycemia). The signs of hypoglycemia include:
Insulin products can low potassium to dangerous levels if taken inappropriately. Tell your doctor if you have a history of potassium that has been too high or too low.
If you have reduced kidney or liver function, your insulin dose may need to be reduced.
The most common side effects of APIDRA insulin can include: